{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:06:50Z","timestamp":1792782410027,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum K\u00f6ln","id":[{"id":"https:\/\/ror.org\/05mxhda18","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Die massive\/massebildende duktul\u00e4re Reaktion (MDR) der Leber ist eine Form ausgedehnten parenchymat\u00f6sen Remodellings unter der Bedingung fokaler relativer Isch\u00e4mie. Diese pseudotumor\u00f6se Reaktion des Leberparenchyms wird durch eine lokal ausgedehnte Okklusion hepatoven\u00f6ser, portoven\u00f6ser und sinusoidaler Blutgef\u00e4\u00dfe hervorgerufen. Oft ist eine angioinvasive Obliteration durch ein koinzidentes Malignom die Ursache. Aber auch ein Auftreten im nichtmalignen Kontext in einer Leberzirrhose oder nach ausgedehnten Lebernekrosen ist m\u00f6glich. Nicht immer gelingt die sichere pr\u00e4interventionelle Einordnung, sodass eine leberbioptische Abgrenzung notwendig ist.<\/jats:p>","DOI":"10.1007\/s00104-026-02530-0","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:20:14Z","timestamp":1782213614000},"page":"810-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Massive\/massebildende duktul\u00e4re Reaktion (MDR) bei angioinvasivem hepatozellul\u00e4rem Karzinom","Massive\/mass-forming ductular reaction (MDR) in angioinvasive hepatocellular carcinoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Anne Kristin","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"3","key":"2530_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","volume":"67","author":"S Lee","year":"2017","unstructured":"Lee\u00a0S, Kim\u00a0SH, Lee\u00a0JE, Sinn\u00a0DH, Park\u00a0CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J\u00a0Hepatol Suppl 67(3):526\u2013534. https:\/\/doi.org\/10.1016\/j.jhep.2017.04.024","journal-title":"J Hepatol"},{"issue":"10","key":"2530_CR2","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1007\/s00330-024-10671-1","volume":"34","author":"TH Kim","year":"2024","unstructured":"Kim\u00a0TH, Woo\u00a0S, Lee\u00a0DH, Do\u00a0RK, Chernyak\u00a0V (2024) MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a\u00a0systematic review and meta-analysis. Eur Radiol 34(10):6896\u20136907. https:\/\/doi.org\/10.1007\/s00330-024-10671-1","journal-title":"Eur Radiol"},{"issue":"11","key":"2530_CR3","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/PAS.0000000000002449","volume":"49","author":"AK Fischer","year":"2025","unstructured":"Fischer\u00a0AK, B\u00fcttner\u00a0R, Fischer\u00a0HP (2025) Massive\/Mass-forming Ductular Reaction Associated With Vascular Occlusion in Various Underlying Basic Liver Diseases. Am J Surg Pathol 49(11):1180\u20131190. https:\/\/doi.org\/10.1097\/PAS.0000000000002449","journal-title":"Am J Surg Pathol"},{"key":"2530_CR4","series-title":"WHO Classification of Tumours Series","volume-title":"Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board (2019) Digestive system tumours, 5.\u00a0Aufl. WHO Classification of Tumours Series. International Agency for Research on Cancer, Lyon","edition":"5"},{"key":"2530_CR5","series-title":"AFIP Atlas of Tumor Pathology","doi-asserted-by":"publisher","DOI":"10.55418\/9781933477411","volume-title":"Tumors of the liver","author":"M Torbenson","year":"2018","unstructured":"Torbenson\u00a0M, Zeh\u00a0Y, Yeh\u00a0MM (2018) Tumors of the liver. AFIP Atlas of Tumor Pathology, Bd 27"},{"issue":"11","key":"2530_CR6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","volume":"36","author":"Y Nakanuma","year":"2012","unstructured":"Nakanuma\u00a0Y, Sato\u00a0Y, Ikeda\u00a0H, Harada\u00a0K, Kobayashi\u00a0M, Sano\u00a0K, Uehara\u00a0T, Yamamoto\u00a0M, Ariizumi\u00a0S, Park\u00a0YN, Choi\u00a0JH, Yu\u00a0E (2012) Intrahepatic cholangiocarcinoma with predominant \u201eductal plate malformation\u201c pattern: a new subtype. Am J Surg Pathol 36(11):1629\u20131635. https:\/\/doi.org\/10.1097\/PAS.0b013e31826e0249","journal-title":"Am J Surg Pathol"},{"key":"2530_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00292-006-0839-9","volume":"27","author":"HP Fischer","year":"2006","unstructured":"Fischer\u00a0HP, Zhou\u00a0H (2006) Leberparenchymknoten bei pathologischer hepatischer Vaskularisation\/Perfusion. Pathologie 27:273\u2013283. https:\/\/doi.org\/10.1007\/s00292-006-0839-9","journal-title":"Pathologe"},{"issue":"5","key":"2530_CR8","first-page":"551","volume":"24","author":"H Popper","year":"1957","unstructured":"Popper\u00a0H, Kent\u00a0G, Stein\u00a0R (1957) Ductular cell reaction in the liver in hepatic injury. J\u00a0Mt Sinai Hosp N Y 24(5):551\u2013556","journal-title":"J Mt Sinai Hosp N Y"},{"issue":"6","key":"2530_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0344-0338(11)80870-8","volume":"191","author":"V Desmet","year":"1995","unstructured":"Desmet\u00a0V, Roskams\u00a0T, Van Eyken\u00a0P (1995) Ductular reaction in the liver. Pathol Res Pract 191(6):513\u2013524. https:\/\/doi.org\/10.1016\/s0344-0338(11)80870-8","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2530_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00428-011-1048-3","volume":"458","author":"VJ Desmet","year":"2011","unstructured":"Desmet\u00a0VJ (2011) Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered. Virchows Arch 458(3):251\u2013259. https:\/\/doi.org\/10.1007\/s00428-011-1048-3","journal-title":"Virchows Arch"},{"issue":"6","key":"2530_CR11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/hep.20130","volume":"39","author":"TA Roskams","year":"2004","unstructured":"Roskams\u00a0TA, Theise\u00a0ND, Balabaud\u00a0C et\u00a0al (2004) Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39(6):1739\u20131745. https:\/\/doi.org\/10.1002\/hep.20130","journal-title":"Hepatology"},{"issue":"4","key":"2530_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2559.2010.03668.x","volume":"57","author":"E Tur\u00e1nyi","year":"2010","unstructured":"Tur\u00e1nyi\u00a0E, Dezs\u00f6\u00a0K, Csomor\u00a0J, Schaff\u00a0Z, Paku\u00a0S, Nagy\u00a0P (2010) Immunohistochemical classification of ductular reactions in human liver. Histopathology 57(4):607\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03668.x","journal-title":"Histopathology"},{"issue":"5","key":"2530_CR13","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/hep.24613","volume":"54","author":"AS Gouw","year":"2011","unstructured":"Gouw\u00a0AS, Clouston\u00a0AD, Theise\u00a0ND (2011) Ductular reactions in human liver: diversity at the interface. Hepatology 54(5):1853\u20131863. https:\/\/doi.org\/10.1002\/hep.24613","journal-title":"Hepatology"},{"issue":"5","key":"2530_CR14","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/hep.27706","volume":"61","author":"AE Stueck","year":"2015","unstructured":"Stueck\u00a0AE, Wanless\u00a0IR (2015) Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis. Hepatology 61(5):1696\u20131707. https:\/\/doi.org\/10.1002\/hep.27706","journal-title":"Hepatology"},{"issue":"28","key":"2530_CR15","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1038\/sj.onc.1207634","volume":"23","author":"M Al-Fageeh","year":"2004","unstructured":"Al-Fageeh\u00a0M, Li\u00a0Q, Dashwood\u00a0WM, Myzak\u00a0MC, Dashwood\u00a0RH (2004) Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32. Oncogene 23(28):4839\u20134846. https:\/\/doi.org\/10.1038\/sj.onc.1207634","journal-title":"Oncogene"},{"key":"2530_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105879","volume":"163","author":"A Joldoshova","year":"2025","unstructured":"Joldoshova\u00a0A, Khandakar\u00a0B, Lee\u00a0H, Lam\u00a0R, Jain\u00a0D (2025) Biliary pseudo tumor associated with hepatic atrophy. Hum Pathol Rep 163:105879. https:\/\/doi.org\/10.1016\/j.humpath.2025.105879","journal-title":"Hum Pathol"},{"key":"2530_CR17","volume-title":"Digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board (2019) Digestive system tumours, 5th edn.\u00a0Aufl. International Agency for Research on Cancer, Lyon, France","edition":"5th edn"},{"issue":"32","key":"2530_CR18","first-page":"522","volume":"47","author":"H Zhou","year":"2000","unstructured":"Zhou\u00a0H, Wolff\u00a0M, Pauleit\u00a0D, Fischer\u00a0HP, Pfeifer\u00a0U (2000) Multiple macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case reports and review of the literature. Hepatogastroenterology 47(32):522\u2013527","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"2530_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/PAS.0000000000000125","volume":"38","author":"M Sasaki","year":"2014","unstructured":"Sasaki\u00a0M, Matsubara\u00a0T, Kakuda\u00a0Y, Sato\u00a0Y, Nakanuma\u00a0Y (2014) Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma. Am J Surg Pathol 38(3):364\u2013369. https:\/\/doi.org\/10.1097\/PAS.0000000000000125","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2530_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","volume":"17","author":"DR Borger","year":"2012","unstructured":"Borger\u00a0DR, Tanabe\u00a0KK, Fan\u00a0KC, Lopez\u00a0HU, Fantin\u00a0VR, Straley\u00a0KS, Schenkein\u00a0DP, Hezel\u00a0AF, Ancukiewicz\u00a0M, Liebman\u00a0HM, Kwak\u00a0EL, Clark\u00a0JW, Ryan\u00a0DP, Deshpande\u00a0V, Dias-Santagata\u00a0D, Ellisen\u00a0LW, Zhu\u00a0AX, Iafrate\u00a0AJ (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17(1):72\u201379. https:\/\/doi.org\/10.1634\/theoncologist.2011-0386","journal-title":"Oncologist"},{"issue":"25","key":"2530_CR21","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/onc.2012.315","volume":"32","author":"P Wang","year":"2013","unstructured":"Wang\u00a0P, Dong\u00a0Q, Zhang\u00a0C, Kuan\u00a0PF, Liu\u00a0Y, Jeck\u00a0WR, Andersen\u00a0JB, Jiang\u00a0W, Savich\u00a0GL, Tan\u00a0TX, Auman\u00a0JT, Hoskins\u00a0JM, Misher\u00a0AD, Moser\u00a0CD, Yourstone\u00a0SM, Kim\u00a0JW, Cibulskis\u00a0K, Getz\u00a0G, Hunt\u00a0HV, Thorgeirsson\u00a0SS, Roberts\u00a0LR, Ye\u00a0D, Guan\u00a0KL, Xiong\u00a0Y, Qin\u00a0LX, Chiang\u00a0DY (2013) Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32(25):3091\u20133100. https:\/\/doi.org\/10.1038\/onc.2012.315","journal-title":"Oncogene"},{"issue":"11","key":"2530_CR22","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","volume":"18","author":"F Farshidfar","year":"2017","unstructured":"Farshidfar\u00a0F, Zheng\u00a0S, Gingras\u00a0MC, Newton\u00a0Y, Shih\u00a0J, Robertson\u00a0AG, Hinoue\u00a0T, Hoadley\u00a0KA, Gibb\u00a0EA, Roszik\u00a0J, Covington\u00a0KR, Wu\u00a0WCC, Shinbrot\u00a0E, Stransky\u00a0N, Hegde\u00a0A, Yang\u00a0JD, Reznik\u00a0E, Sadeghi\u00a0S, Pedamallu\u00a0CS, Ojesina\u00a0AI, Hess\u00a0JM, Auman\u00a0JT, Rhie\u00a0SK, Bowlby\u00a0R, Borad\u00a0MJ, Cancer Genome Atlas Network, Zhu\u00a0AX, Stuart\u00a0JM, Sander\u00a0C, Akbani\u00a0R, Cherniack\u00a0AD, Deshpande\u00a0V, Mounajjed\u00a0T, Foo\u00a0WC, Torbenson\u00a0MS, Kleiner\u00a0DE, Laird\u00a0PW, Wheeler\u00a0DA, McRee\u00a0AJ, Bathe\u00a0OF, Andersen\u00a0JB, Bardeesy\u00a0N, Roberts\u00a0LR, Kwong\u00a0LN (2017) Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep Med 18(11):2780\u20132794. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.033","journal-title":"Cell Rep"},{"issue":"4","key":"2530_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.26890","volume":"59","author":"Y Arai","year":"2014","unstructured":"Arai\u00a0Y, Totoki\u00a0Y, Hosoda\u00a0F, Shirota\u00a0T, Hama\u00a0N, Nakamura\u00a0H, Ojima\u00a0H, Furuta\u00a0K, Shimada\u00a0K, Okusaka\u00a0T, Kosuge\u00a0T, Shibata\u00a0T (2014) Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. Hepatology 59(4):1427\u20131434. https:\/\/doi.org\/10.1002\/hep.26890","journal-title":"Hepatology"},{"issue":"9","key":"2530_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura\u00a0H, Arai\u00a0Y, Totoki\u00a0Y, Shirota\u00a0T, Elzawahry\u00a0A, Kato\u00a0M, Hama\u00a0N, Hosoda\u00a0F, Urushidate\u00a0T, Ohashi\u00a0S, Hiraoka\u00a0N, Ojima\u00a0H, Shimada\u00a0K, Okusaka\u00a0T, Kosuge\u00a0T, Miyagawa\u00a0S, Shibata\u00a0T (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010. https:\/\/doi.org\/10.1038\/ng.3375","journal-title":"Nat Genet"},{"issue":"3","key":"2530_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2206834","volume":"388","author":"L Goyal","year":"2023","unstructured":"Goyal\u00a0L, Meric-Bernstam\u00a0F, Hollebecque\u00a0A, Valle\u00a0JW, Morizane\u00a0C, Karasic\u00a0TB, Abrams\u00a0TA, Furuse\u00a0J, Kelley\u00a0RK, Cassier\u00a0PA, Kl\u00fcmpen\u00a0HJ, Chang\u00a0HM, Chen\u00a0LT, Tabernero\u00a0J, Oh\u00a0DY, Mahipal\u00a0A, Moehler\u00a0M, Mitchell\u00a0EP, Komatsu\u00a0Y, Masuda\u00a0K, Ahn\u00a0D, Epstein\u00a0RS, Halim\u00a0AB, Fu\u00a0Y, Salimi\u00a0T, Wacheck\u00a0V, He\u00a0Y, Liu\u00a0M, Benhadji\u00a0KA, Bridgewater\u00a0JA, FOENIX-CCA2 Study Investigators (2023) Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med 388(3):228\u2013239. https:\/\/doi.org\/10.1056\/NEJMoa2206834","journal-title":"N Engl J Med"},{"issue":"8","key":"2530_CR26","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.humpath.2014.03.014","volume":"45","author":"RP Graham","year":"2014","unstructured":"Graham\u00a0RP, Barr Fritcher\u00a0EG, Pestova\u00a0E, Schulz\u00a0J, Sitailo\u00a0LA, Vasmatzis\u00a0G, Murphy\u00a0SJ, McWilliams\u00a0RR, Hart\u00a0SN, Halling\u00a0KC, Roberts\u00a0LR, Gores\u00a0GJ, Couch\u00a0FJ, Zhang\u00a0L, Borad\u00a0MJ, Kipp\u00a0BR (2014) Fibroblast growth factor receptor\u00a02 translocations in intrahepatic cholangiocarcinoma. Hum Pathol Rep 45(8):1630\u20131638. https:\/\/doi.org\/10.1016\/j.humpath.2014.03.014","journal-title":"Hum Pathol"},{"key":"2530_CR27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4087","volume":"37","author":"MM Javle","year":"2019","unstructured":"Javle\u00a0MM, Murugesan\u00a0K, Shroff\u00a0RT, Borad\u00a0MJ, Abdel-Wahab\u00a0R, Schrock\u00a0AB et\u00a0al (2019) Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH) [abstract]. J\u00a0Clin Oncol 37:4087. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.4087","journal-title":"J Clin Oncol"},{"key":"2530_CR28","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery\u00a0MA, Ptashkin\u00a0R, Jordan\u00a0E, Berger\u00a0MF, Zehir\u00a0A, Capanu\u00a0M et\u00a0al (2018) Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention. Clin Cancer Res 24:4154\u20134161. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0078","journal-title":"Clin Cancer Res"},{"key":"2530_CR29","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao\u00a0Y et\u00a0al (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45:1470\u20131473","journal-title":"Nat Genet"},{"key":"2530_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/modpathol.2013.206","volume":"27","author":"B Goeppert","year":"2014","unstructured":"Goeppert\u00a0B, Frauenschuh\u00a0L, Renner\u00a0M, Roessler\u00a0S, Stenzinger\u00a0A, Klauschen\u00a0F et\u00a0al (2014) BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma. Mod Pathol 27:1028\u20131034. https:\/\/doi.org\/10.1038\/modpathol.2013.206","journal-title":"Mod Pathol"},{"issue":"2","key":"2530_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0168-8278(01)00106-4","volume":"35","author":"H Momoi","year":"2001","unstructured":"Momoi\u00a0H, Itoh\u00a0T, Nozaki\u00a0Y, Arima\u00a0Y, Okabe\u00a0H, Satoh\u00a0S, Toda\u00a0Y, Sakai\u00a0E, Nakagawara\u00a0K, Flemming\u00a0P, Yamamoto\u00a0M, Shimahara\u00a0Y, Yamaoka\u00a0Y, Fukumoto\u00a0M (2001) Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. J\u00a0Hepatol 35(2):235\u2013244. https:\/\/doi.org\/10.1016\/s0168-8278(01)00106-4","journal-title":"J Hepatol"},{"issue":"1","key":"2530_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/hep.27133","volume":"61","author":"A Pujals","year":"2015","unstructured":"Pujals\u00a0A, Amaddeo\u00a0G, Castain\u00a0C, Bioulac-Sage\u00a0P, Compagnon\u00a0P, Zucman-Rossi\u00a0J, Azoulay\u00a0D, Leroy\u00a0K, Zafrani\u00a0ES, Calderaro\u00a0J (2015) BRAF V600E mutations in bile duct adenomas. Hepatology 61(1):403\u2013405. https:\/\/doi.org\/10.1002\/hep.27133","journal-title":"Hepatology"},{"issue":"4","key":"2530_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/his.12674","volume":"67","author":"A Pujals","year":"2015","unstructured":"Pujals\u00a0A, Bioulac-Sage\u00a0P, Castain\u00a0C, Charpy\u00a0C, Zafrani\u00a0ES, Calderaro\u00a0J (2015) BRAF V600E mutational status in bile duct adenomas and hamartomas. Histopathology 67(4):562\u2013567. https:\/\/doi.org\/10.1111\/his.12674","journal-title":"Histopathology"},{"issue":"2","key":"2530_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/his.14932","volume":"83","author":"M Sasaki","year":"2023","unstructured":"Sasaki\u00a0M, Sato\u00a0Y, Nakanuma\u00a0Y (2023) Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components. Histopathology 83(2):298\u2013309. https:\/\/doi.org\/10.1111\/his.14932","journal-title":"Histopathology"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-026-02530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-026-02530-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-026-02530-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:24:42Z","timestamp":1790159082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-026-02530-0"}},"subtitle":["Pathogenese und Differenzialdiagnosen eines hepatischen Pseudotumors","Pathogenesis and differential diagnoses of a\u00a0hepatic pseudotumor"],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1007\/s00104-026-02530-0","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K.\u00a0Fischer, R.\u00a0B\u00fcttner, T.\u00a0Persigehl und H.-P.\u00a0Fischer geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die Experimente wurden vom Institutional Review Board der Medizinischen Fakult\u00e4t der Universit\u00e4t zu K\u00f6ln gem\u00e4\u00df den Helsinki-Kriterien genehmigt. Alle Patienten gaben ihre Einwilligung nach Aufkl\u00e4rung und hatten die M\u00f6glichkeit, diese jederzeit zu widerrufen (Ethik-Zulassungsnummer Nr. 13-091).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}